Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…
BOSTON–(BUSINESS WIRE)–Jnana Therapeutics today announced the appointment of Donald Nicholson, Ph.D., an accomplished scientist and executive, as chair of its…
Mallinckrodt’s retrospective study has shown the effectiveness of Extracorporeal Photopheresis (ECP), as an adjunct to local standard therapy, in lung transplant recipients with Bronchiolitis Obliterans Syndrome (BOS).
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today…
WASHINGTON–(BUSINESS WIRE)–Senator Johnny Isakson was recognized today by the Biotechnology Innovation Organization (BIO) for his leadership as an Innovator in…
WASHINGTON–(BUSINESS WIRE)–Congressman Doug Collins was recognized today by the Biotechnology Innovation Organization (BIO) for his leadership as an Innovator in…
Myriad Genetics, AstraZeneca, and Merck have expanded their companion diagnostic collaboration, to use BRACAnalysis CDx to identify germline BRCA mutations in…
Approval of expanded indication based predominately on real-world data NEW YORK–(BUSINESS WIRE)–Pfizer (NYSE:PFE) today announced that the U.S. Food and…
New module available as a standalone solution or fully integral with AMPLEXOR’s Life Sciences Suite BROOMFIELD, Colo.–(BUSINESS WIRE)–The Life Sciences…
The First HepQuant SHUNT™ Data From An Interventional Drug Study in NASH DENVER–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/NASH?src=hash” target=”_blank”gt;#NASHlt;/agt;–HepQuant, LLC, a Greenwood Village,…